Biotech Values

[wallstarb]

You are right it seems a little over priced sicne they did the pipe. But it should have been able to hold the 10.75 placement price.

Just shows a lot of weakness.

As an example THLD which did a $35m pipe which issued 110% new shares actually did it at a premium and is now nearly 100% over the PIPE price. So it shows there was demand for it. Those shares arent even registered shares - I'm thinking some of the MNTA pipe buyers may be selling in the open market to limit their losses since it broke the 10.50 level.